SCHEDULE 13G/A - Hinge Health, Inc. (0001673743) (Subject)

SCHEDULE 13G - Hinge Health, Inc. (0001673743) (Subject)

SCHEDULE 13G - Hinge Health, Inc. (0001673743) (Subject)

144 - Hinge Health, Inc. (0001673743) (Subject)

SCHEDULE 13G - Hinge Health, Inc. (0001673743) (Subject)

144 - Hinge Health, Inc. (0001673743) (Subject)

144 - Hinge Health, Inc. (0001673743) (Subject)

144 - Hinge Health, Inc. (0001673743) (Subject)

144 - Hinge Health, Inc. (0001673743) (Subject)

144 - Hinge Health, Inc. (0001673743) (Subject)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

Wells Fargo initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $68.00

Robert W. Baird initiated coverage of Hinge Health with a rating of Neutral and set a new price target of $56.00

Citizens JMP initiated coverage of Hinge Health with a rating of Mkt Outperform and set a new price target of $58.00

William Blair initiated coverage of Hinge Health with a rating of Outperform

Truist initiated coverage of Hinge Health with a rating of Buy and set a new price target of $48.00

Stifel initiated coverage of Hinge Health with a rating of Buy and set a new price target of $48.00

Raymond James initiated coverage of Hinge Health with a rating of Outperform and set a new price target of $45.00

Piper Sandler initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $41.00

Morgan Stanley initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $46.00

Needham initiated coverage of Hinge Health with a rating of Buy and set a new price target of $47.00

Today, Hinge Health (NYSE:HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today's fragmented healthcare system leaves many people unsure how to pursue treatment for MSK pain. Hinge Health surveyed 1,000 people living with MSK pain alongside 295 healthcare providers to understand the systemic challenges and opportunities for industry-wide improvements. The dual-perspective survey – along with real patient and provider stories – maps a clear path to more effective, unified care. "While Hinge Health's digital physical therapy program has dramatically increased access, MSK care still feels like a maze for too many people," said Dr. Jeffrey Krauss, MD,

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the fourth quarter and full year 2025 after the U.S. financial markets close on Tuesday, February 10, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, st

Hinge Health, Inc. (NYSE:HNGE) today announced a new study showing that participants in its chronic back pain program had substantially fewer imaging visits, such as X-rays and MRIs, compared to a similar group of individuals who sought traditional PT care. The peer-reviewed study, published in The Journal of Health Economics and Outcomes Research found that of the 4,330 participants, those who used Hinge Health had 60% fewer imaging visits for low back pain at three months compared to the control group. Low back pain is one of the most common musculoskeletal (MSK) conditions with lifetime incidence as high as 84%. While imaging for low back pain has increased over the last decade, eviden

Hinge Health, Inc. (NYSE:HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. "During the first three quarters of 2025, we generated $108 million in cash from operations and $118 million in free cash flow1, reflecting the strength and scalability of our business model," said James Budge, CFO, Hinge Health. "We maintain a robust balance sheet, with nearly $500 million in cash and investments as of the end of Q3 2025. Notably, substantially all of our IPO proceeds were used towards tax obligations for employee RSU settlement and a small secondary for pre-IPO investors. None was put to our balance sheet for long-term use." "Our strong fr

Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the third quarter ended September 30, 2025. "With healthcare costs rising dramatically, our mission to automate care delivery has never been more urgent," said Daniel Perez, Co-Founder and CEO, Hinge Health. "This quarter we surpassed 1.5 million lifetime members, delivered year-over-year revenue growth of 53%, and generated record free cash flow. Our AI-powered platform is transforming care at scale, increasing engagement for our members and reducing healthcare costs for our clients." Third Quarter 2025 Financial Highlights: Revenue increased 53% year-over-year to $154.2 million compared to revenue of $100.6 million i

Hinge Health, Inc. (NYSE:HNGE) today announced two AI-powered care tools: Movement Analysis uses computer vision to set a new standard for tracking musculoskeletal (MSK) outcomes, and Robin is an AI Care Assistant that provides instant support for members. Hinge Health also published its AI care principles, which guide the development of AI across its platform. "Our thoughtful investments in AI are transforming how our members experience care," said Daniel Perez, Co-Founder and CEO of Hinge Health. "Our new Movement Analysis and our AI Care Assistant, Robin, are the latest examples of how we're using technology to make care more accessible, personalized, and effective." Reimagining outc

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended September 30, 2025, after the U.S. markets close on Tuesday, November 4, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting with

Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the second quarter ended June 30, 2025. "In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow margin, underlining the market's embrace of our AI-powered platform," said Daniel Perez, Co-Founder and CEO, Hinge Health. "The journey of automating healthcare delivery will be challenging, but we're excited about our momentum and are moving with haste to capture this opportunity." Second Quarter 2025 Financial Highlights: Revenue increased 55% year-over-year to $139.1 million compared to revenue of $89.8 million in Q2 2024. GAAP gross margin was 70% compared to 74% in Q2 2024. Non-GAAP gr

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting w

Combined with Hinge Health's AI-powered exercise therapy program, HingeSelect adds access to high-quality in-person providers for members at up to 50% below PPO rates Hinge Health, Inc. (NYSE:HNGE), today announced the launch of HingeSelect, a high-performance provider network for musculoskeletal (MSK) care. Hinge Health's technology and in-house orthopedic physicians triage and direct downstream care, prioritizing the most appropriate evidence-based treatment. When in-person care, such as imaging or injections is required, members are seamlessly connected to pre-vetted providers at up to 50% below PPO rates. Combined with Hinge Health's AI-powered digital exercise therapy, HingeSelect pr

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the fourth quarter and full year 2025 after the U.S. financial markets close on Tuesday, February 10, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, st

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended September 30, 2025, after the U.S. markets close on Tuesday, November 4, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting with

Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the second quarter ended June 30, 2025. "In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow margin, underlining the market's embrace of our AI-powered platform," said Daniel Perez, Co-Founder and CEO, Hinge Health. "The journey of automating healthcare delivery will be challenging, but we're excited about our momentum and are moving with haste to capture this opportunity." Second Quarter 2025 Financial Highlights: Revenue increased 55% year-over-year to $139.1 million compared to revenue of $89.8 million in Q2 2024. GAAP gross margin was 70% compared to 74% in Q2 2024. Non-GAAP gr

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting w